T. Rowe Price Associates’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.24M Buy
238,797
+64,532
+37% +$404K ﹤0.01% 2044
2025
Q4
$1.27M Buy
174,265
+25,199
+17% +$244K ﹤0.01% 1973
2025
Q3
$1.49M Sell
149,066
-14,369
-9% -$159K ﹤0.01% 1872
2025
Q2
$1.48M Buy
163,435
+18,134
+12% +$118K ﹤0.01% 1792
2025
Q1
$934K Buy
145,301
+5,260
+4% +$46.8K ﹤0.01% 1992
2024
Q4
$1.33M Buy
140,041
+26,508
+23% +$233K ﹤0.01% 1847
2024
Q3
$928K Buy
113,533
+9,842
+9% +$102K ﹤0.01% 2003
2024
Q2
$1.4M Buy
103,691
+12,355
+14% +$103K ﹤0.01% 1736
2024
Q1
$641K Buy
91,336
+5,749
+7% +$49.9K ﹤0.01% 2106
2023
Q4
$938K Buy
85,587
+6,977
+9% +$68.5K ﹤0.01% 1896
2023
Q3
$864K Buy
78,610
+4,060
+5% +$58K ﹤0.01% 1863
2023
Q2
$1.18M Buy
74,550
+9,861
+15% +$115K ﹤0.01% 1724
2023
Q1
$844K Buy
64,689
+2,305
+4% +$18.9K ﹤0.01% 1869
2022
Q4
$679K Sell
62,384
-2,097
-3% -$25.8K ﹤0.01% 1988
2022
Q3
$1.03M Buy
64,481
+8,504
+15% +$126K ﹤0.01% 1730
2022
Q2
$436K Buy
55,977
+24,206
+76% +$228K ﹤0.01% 2276
2022
Q1
$397K Buy
31,771
+10,285
+48% +$144K ﹤0.01% 2439
2021
Q4
$513K Buy
+21,486
New +$520K ﹤0.01% 2379

Other funds holding ENVX

T. Rowe Price Associates's ENVX Position: Q1 2026 in Review

T. Rowe Price Associates increased its Enovix (ENVX) stake by 37% in Q1 2026, buying an estimated $404K and bringing the position to 238,797 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2044.

T. Rowe Price Associates first reported a position in ENVX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.49M in Q3 2025. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • T. Rowe Price Associates held 238,797 shares of Enovix worth $1.24M as of Q1 2026.
  • T. Rowe Price Associates bought 64,532 Enovix shares in Q1 2026, an estimated $404K.
  • Enovix made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2044 holding.
  • T. Rowe Price Associates first reported a position in Enovix in Q4 2021 and has held it in 18 quarters since.
  • T. Rowe Price Associates's Enovix position peaked at $1.49M in Q3 2025.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.